Has Stephen Pham, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,734 in general payments to Stephen Pham, MD across 29 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Pham, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Pham, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Pham, MD

Emergency Medicine · Orlando, FLNPI 1619079241

Payments from drug & device makers

$3,734in general payments, 2019–2025

Across 29 payments — averaging $128.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$2K
La Jolla Pharmaceutical Company$545
Johnson & Johnson$508
AstraZeneca$239
GSK$231
Merck$160
plus $502 from 6 others

What the payments were for

Consulting fees$87023%
Food & beverage$2,86477%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead	8	$1,550
La Jolla Pharmaceutical Company	5	$545
Johnson & Johnson	4	$508
AstraZeneca(2 entities)	2	$239
GSK	2	$231
Merck	2	$160
Ferring Pharmaceuticals Inc.	1	$145
Novo Nordisk	1	$114
Fisher Scientific Company L.L.C.	1	$113
Recordati_rare_diseases_inc.	1	$92
Teva Pharmaceuticals USA, Inc.	1	$22
Pfizer	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,734 in reported general payments places this provider in the 95th percentile of 3,289 emergency medicine providers in Florida.

See all emergency medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$17,196

Medicare patients

Services billed

152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other emergency medicine in Orlando

Beatriz ColonOrlando$1.8M
Elizabeth PhillipsOrlando$848K
Philip GiordanoOrlando$64K
Linda PapaOrlando$27K
Esteban OliveraKissimmee$15.7M
Edgardo RiveraLeesburg$14.3M
Mazyar RouhaniWeaston$6.6M
Shital-Hiten UpadhyaySt Petersburg$6.1M
Abid ChaudhryHomestead$4.8M
Christine MurphyClermont$3.6M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →